Search details
1.
Declining trends in early warning indicators for HIV drug resistance in Cameroon from 2008-2010: lessons and challenges for low-resource settings.
BMC Public Health
; 13: 308, 2013 Apr 08.
Article
in English
| MEDLINE | ID: mdl-23565992
2.
Laboratory Based Surveillance of HIV-1 Acquired Drug Resistance in Cameroon: Implications for Use of Tenofovir-Lamivudine-Dolutegravir (TLD) as Second- or Third-Line Regimens.
Viruses
; 15(8)2023 08 02.
Article
in English
| MEDLINE | ID: mdl-37632026
3.
Viral suppression in the era of transition to dolutegravir-based therapy in Cameroon: Children at high risk of virological failure due to the lowly transition in pediatrics.
Medicine (Baltimore)
; 102(20): e33737, 2023 May 19.
Article
in English
| MEDLINE | ID: mdl-37335723
4.
Translating Technical Support Into Country Action: The Role of the Interagency Task Team on the Prevention and Treatment of HIV Infection in Pregnant Women, Mothers, and Children in the Global Plan Era.
J Acquir Immune Defic Syndr
; 75 Suppl 1: S7-S16, 2017 May 01.
Article
in English
| MEDLINE | ID: mdl-28398992
5.
Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations.
PLoS One
; 10(6): e0129210, 2015.
Article
in English
| MEDLINE | ID: mdl-26083364
6.
Population-based monitoring of emerging HIV-1 drug resistance on antiretroviral therapy and associated factors in a sentinel site in Cameroon: low levels of resistance but poor programmatic performance.
PLoS One
; 8(8): e72680, 2013.
Article
in English
| MEDLINE | ID: mdl-23991142
7.
Early warning indicators for HIV drug resistance in Cameroon during the year 2010.
PLoS One
; 7(5): e36777, 2012.
Article
in English
| MEDLINE | ID: mdl-22615810
Results
1 -
7
de 7
1
Next >
>>